Beta Bionics, Inc. (BBNX) vs PROCEPT BioRobotics Corporation (PRCT)
Beta Bionics, Inc. and PROCEPT BioRobotics Corporation are both Medical Devices companies. Beta Bionics, Inc. is the larger, with a market value of $1.2B against $1.0B — 1.2× the size. Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 22.7%. PROCEPT BioRobotics Corporation has the higher net margin (−32.5% vs −61.3%) and the higher return on invested capital (−43.6% vs −68.5%). Across the 17 metrics below, PROCEPT BioRobotics Corporation leads on 11 and Beta Bionics, Inc. on 6.
Valuation
Profitability
| Metric | BBNX | PRCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.31% | 64.22% | 56.01% |
| Operating margin | (69.75%) | (33.86%) | (15.03%) |
| Net margin | (61.32%) | (32.54%) | (20.40%) |
| Free cash flow margin | (284.13%) | (25.17%) | (7.24%) |
| Return on equity | (26.16%) | (30.24%) | (15.32%) |
| Return on assets | (23.45%) | (22.12%) | (19.72%) |
| Return on invested capital | (68.47%) | (43.57%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack